Tekna reports 61% revenue growth and a record powder backlog
The plasma-atomized powder maker cites aerospace, defense and medical demand, days after a CAD 1.2 million titanium order from a US implant manufacturer.

What happened
Tekna, the Quebec-based plasma-atomized powder and plasma-systems maker listed in Oslo, reported third-quarter 2026 revenue of CAD 13.4 million on November 5, up 61% from CAD 8.3 million. Adjusted EBITDA was CAD 2.9 million, a 21.5% margin, against CAD 0.5 million a year earlier; reported EBITDA of CAD 1.9 million includes CAD 1.0 million of non-recurring items. Contribution margin fell to 50.7% from 57.6% on a larger share of lower-margin materials sales.
Order intake roughly doubled to CAD 10.6 million and the backlog rose to CAD 25.5 million from CAD 18.2 million, which Tekna says extends visibility into 2027. It attributes demand for its additive manufacturing powders to aerospace, defense and medical customers and to reshoring. On November 3 it announced orders worth CAD 1.2 million for Ti-6Al-4V powder sized for laser powder bed fusion from an unnamed major US contract manufacturer of medical implants, with deliveries through 2027, following a CAD 1.6 million European medical order in October.
Tekna gives no quarterly or full-year guidance beyond a long-term ambition of double-digit annual growth through 2030. The release text omits the net result and cash balance, which are in the attached interim report, and does not split materials and systems revenue.
Read the sources
Primary-source reporting; this is not a hands-on review. Sources checked Nov 6, 2026.